Monopar Therapeutics Inc.
1000
Skokie Blvd., Suite 350
Wilmette,
Illinois 60091
November
7, 2019
VIA EDGAR
US
Securities and Exchange Commission
Division
of Corporation Finance
100 F
Street, NE
Washington,
DC 20549
Re:
Monopar
Therapeutics Inc.
Registration Statement on Form S-1
File No. 333-233303
Ladies
and Gentlemen:
In
prior correspondence, dated November 5, 2019, Monopar Therapeutics
Inc. (the “Company”) requested that the
above-referenced Registration Statement be declared effective at 4
p.m., Eastern time, on November 7, 2019 (the “Acceleration
Request”). The Acceleration Request is hereby withdrawn by
the Company.
Please
contact John Harrington of Baker & Hostetler LLP at (216)
861-6697 with any questions regarding the foregoing.
Very
truly yours,
Monopar
Therapeutics Inc.
By:
/s/ Chandler D.
Robinson____________
Chandler D.
Robinson
Chief
Executive Officer